{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:22:57Z","timestamp":1792174977569,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1245\/s10434-024-16120-z","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:02:24Z","timestamp":1728478944000},"page":"9007-9013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SDHB-Associated Pheochromocytomas: What is Their Clinical Behavior?"],"prefix":"10.1245","volume":"31","author":[{"given":"Thomas","family":"Szabo Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Tame-Elorduy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Skefos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeena M","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouhammed Amir","family":"Habra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Waguespack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D.","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"issue":"12","key":"16120_CR1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.eprac.2023.07.027","volume":"29","author":"S Sharma","year":"2023","unstructured":"Sharma S, Fishbein L. Diagnosis and management of pheochromocytomas and paragangliomas: a guide for the clinician. Endocr Pract. 2023;29(12):999\u20131006. https:\/\/doi.org\/10.1016\/j.eprac.2023.07.027.","journal-title":"Endocr Pract."},{"issue":"1","key":"16120_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1530\/EJE-20-0628","volume":"184","author":"AA Leung","year":"2021","unstructured":"Leung AA, Pasieka JL, Hyrcza MD, et al. Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study. Eur J Endocrinol. 2021;184(1):19\u201328. https:\/\/doi.org\/10.1530\/EJE-20-0628.","journal-title":"Eur J Endocrinol."},{"issue":"11","key":"16120_CR3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","volume":"8","author":"A Ebbehoj","year":"2020","unstructured":"Ebbehoj A, Li D, Kaur RJ, et al. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(11):894\u2013902. https:\/\/doi.org\/10.1016\/S2213-8587(20)30314-4.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"16120_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","volume":"50","author":"L Fishbein","year":"2021","unstructured":"Fishbein L, Del Rivero J, Else T, et al. The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and management of metastatic and\/or unresectable pheochromocytoma and paraganglioma. Pancreas. 2021;50(4):469\u201393. https:\/\/doi.org\/10.1097\/MPA.0000000000001792.","journal-title":"Pancreas."},{"issue":"6","key":"16120_CR5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1177\/03008916221078621","volume":"108","author":"N Prinzi","year":"2022","unstructured":"Prinzi N, Corti F, Torchio M, et al. Metastatic pheochromocytomas and paragangliomas: Where are we? Tumori J. 2022;108(6):526\u201340. https:\/\/doi.org\/10.1177\/03008916221078621.","journal-title":"Tumori J."},{"issue":"9","key":"16120_CR6","doi-asserted-by":"publisher","first-page":"bvac105","DOI":"10.1210\/jendso\/bvac105","volume":"6","author":"AR Al Subhi","year":"2022","unstructured":"Al Subhi AR, Boyle V, Elston MS. Systematic review: incidence of pheochromocytoma and paraganglioma over 70 years. J Endocr Soc. 2022;6(9):bvac105. https:\/\/doi.org\/10.1210\/jendso\/bvac105.","journal-title":"J Endocr Soc."},{"issue":"2","key":"16120_CR7","doi-asserted-by":"publisher","first-page":"101354","DOI":"10.1016\/j.beem.2019.101354","volume":"34","author":"S Jasim","year":"2020","unstructured":"Jasim S, Jimenez C. Metastatic pheochromocytoma and paraganglioma: management of endocrine manifestations, surgery and ablative procedures, and systemic therapies. Best Pract Res Clin Endocrinol Metab. 2020;34(2):101354. https:\/\/doi.org\/10.1016\/j.beem.2019.101354.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"6","key":"16120_CR8","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342. https:\/\/doi.org\/10.1210\/jc.2014-1498.","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"16120_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41574-023-00926-0","volume":"20","author":"D Ta\u00efeb","year":"2024","unstructured":"Ta\u00efeb D, N\u00f6lting S, Perrier ND, et al. Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert consensus statement. Nat Rev Endocrinol. 2024;20(3):168\u201384. https:\/\/doi.org\/10.1038\/s41574-023-00926-0.","journal-title":"Nat Rev Endocrinol."},{"issue":"4","key":"16120_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000084685","volume":"63","author":"J Favier","year":"2005","unstructured":"Favier J, Bri\u00e8re JJ, Strompf L, et al. Hereditary paraganglioma\/pheochromocytoma and inherited succinate dehydrogenase deficiency. Horm Res Paediatr. 2005;63(4):171\u20139. https:\/\/doi.org\/10.1159\/000084685.","journal-title":"Horm Res Paediatr."},{"issue":"5","key":"16120_CR11","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1210\/endrev\/bnad011","volume":"44","author":"G Eisenhofer","year":"2023","unstructured":"Eisenhofer G, Pamporaki C, Lenders JWM. Biochemical assessment of pheochromocytoma and paraganglioma. Endocr Rev. 2023;44(5):862\u2013909. https:\/\/doi.org\/10.1210\/endrev\/bnad011.","journal-title":"Endocr Rev."},{"key":"16120_CR12","unstructured":"Amin MB, Edge SB, Greene FL, et al. AJCC Cancer Staging Manual. 8th ed.; 2017."},{"issue":"2","key":"16120_CR13","doi-asserted-by":"publisher","first-page":"101416","DOI":"10.1016\/j.beem.2020.101416","volume":"34","author":"A Buffet","year":"2020","unstructured":"Buffet A, Burnichon N, Favier J, Gimenez-Roqueplo AP. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2020;34(2):101416. https:\/\/doi.org\/10.1016\/j.beem.2020.101416.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"1","key":"16120_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Asa SL, Gill AJ, Kimura N, De Krijger RR, Tischler A. Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas. Endocr Pathol. 2022;33(1):90\u2013114. https:\/\/doi.org\/10.1007\/s12022-022-09704-6.","journal-title":"Endocr Pathol."},{"issue":"6","key":"16120_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/jcp.2010.076257","volume":"63","author":"R Chetty","year":"2010","unstructured":"Chetty R. Familial paraganglioma syndromes. J Clin Pathol. 2010;63(6):488\u201391. https:\/\/doi.org\/10.1136\/jcp.2010.076257.","journal-title":"J Clin Pathol."},{"issue":"3","key":"16120_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1530\/ERC-13-0494","volume":"21","author":"N Kimura","year":"2014","unstructured":"Kimura N, Takayanagi R, Takizawa N, et al. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer. 2014;21(3):405\u201314. https:\/\/doi.org\/10.1530\/ERC-13-0494.","journal-title":"Endocr Relat Cancer."},{"issue":"12","key":"16120_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/jmedgenet-2012-101192","volume":"49","author":"LT Van Hulsteijn","year":"2012","unstructured":"Van Hulsteijn LT, Dekkers OM, Hes FJ, Smit JWA, Corssmit EPM. Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis. J Med Genet. 2012;49(12):768\u201376. https:\/\/doi.org\/10.1136\/jmedgenet-2012-101192.","journal-title":"J Med Genet."},{"key":"16120_CR18","doi-asserted-by":"publisher","first-page":"115500","DOI":"10.1016\/j.biopha.2023.115500","volume":"167","author":"C Liu","year":"2023","unstructured":"Liu C, Zhou D, Yang K, Xu N, Peng J, Zhu Z. Research progress on the pathogenesis of the SDHB mutation and related diseases. Biomed Pharmacother. 2023;167:115500. https:\/\/doi.org\/10.1016\/j.biopha.2023.115500.","journal-title":"Biomed Pharmacother."},{"issue":"1","key":"16120_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/jmedgenet-2020-107656","volume":"60","author":"JP Bayley","year":"2023","unstructured":"Bayley JP, Bausch B, Jansen JC, et al. SDHB variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma. J Med Genet. 2023;60(1):25\u201332. https:\/\/doi.org\/10.1136\/jmedgenet-2020-107656.","journal-title":"J Med Genet."},{"issue":"10","key":"16120_CR20","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1210\/clinem\/dgad166","volume":"108","author":"A Fischer","year":"2023","unstructured":"Fischer A, Kloos S, Maccio U, et al. Metastatic pheochromocytoma and paraganglioma: somatostatin receptor 2 expression, genetics, and therapeutic responses. J Clin Endocrinol Metab. 2023;108(10):2676\u201385. https:\/\/doi.org\/10.1210\/clinem\/dgad166.","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"16120_CR21","doi-asserted-by":"publisher","first-page":"e4661","DOI":"10.1210\/clinem\/dgaa608","volume":"105","author":"H Wachtel","year":"2020","unstructured":"Wachtel H, Hutchens T, Baraban E, et al. Predicting metastatic potential in pheochromocytoma and paraganglioma: a comparison of PASS and GAPP scoring systems. J Clin Endocrinol Metab. 2020;105(12):e4661\u201370. https:\/\/doi.org\/10.1210\/clinem\/dgaa608.","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"16120_CR22","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","volume":"8","author":"A Ebbehoj","year":"2020","unstructured":"Ebbehoj A, Li D, Kaur RJ, et al. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(11):894\u2013902. https:\/\/doi.org\/10.1016\/S2213-8587(20)30314-4.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"16120_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","volume":"55","author":"KA Andrews","year":"2018","unstructured":"Andrews KA, Ascher DB, Pires DEV, et al. Tumour risks and genotype\u2013phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB. SDHC and SDHD J Med Genet. 2018;55(6):384\u201394. https:\/\/doi.org\/10.1136\/jmedgenet-2017-105127.","journal-title":"SDHC and SDHD. J Med Genet."},{"issue":"5","key":"16120_CR24","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1210\/clinem\/dgac677","volume":"108","author":"C Jimenez","year":"2023","unstructured":"Jimenez C, Ma J, Roman Gonzalez A, et al. TNM staging and overall survival in patients with pheochromocytoma and sympathetic paraganglioma. J Clin Endocrinol Metab. 2023;108(5):1132\u201342. https:\/\/doi.org\/10.1210\/clinem\/dgac677.","journal-title":"J Clin Endocrinol Metab."},{"key":"16120_CR25","doi-asserted-by":"publisher","first-page":"1137456","DOI":"10.3389\/fendo.2023.1137456","volume":"14","author":"S Martinelli","year":"2023","unstructured":"Martinelli S, Amore F, Canu L, Maggi M, Rapizzi E. Tumour microenvironment in pheochromocytoma and paraganglioma. Front Endocrinol. 2023;14:1137456. https:\/\/doi.org\/10.3389\/fendo.2023.1137456.","journal-title":"Front Endocrinol."},{"issue":"4","key":"16120_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ecl.2019.08.006","volume":"48","author":"SG Tevosian","year":"2019","unstructured":"Tevosian SG, Ghayee HK. Pheochromocytomas and paragangliomas. Endocrinol Metab Clin North Am. 2019;48(4):727\u201350. https:\/\/doi.org\/10.1016\/j.ecl.2019.08.006.","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"1","key":"16120_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/SLA.0000000000002195","volume":"268","author":"A Roman-Gonzalez","year":"2018","unstructured":"Roman-Gonzalez A, Zhou S, Ayala-Ramirez M, et al. Impact of surgical resection of the primary tumor on overall survival in patients with metastatic pheochromocytoma or sympathetic paraganglioma. Ann Surg. 2018;268(1):172\u20138. https:\/\/doi.org\/10.1097\/SLA.0000000000002195.","journal-title":"Ann Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16120-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16120-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16120-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T13:09:27Z","timestamp":1731071367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16120-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":27,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["16120"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16120-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No authors report any proprietary or commercial interest in any product mentioned or concept discussed in this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}